Skip to main content
. 2017 Sep 8;8(44):77649–77672. doi: 10.18632/oncotarget.20765

Table 4. Percentage of cells in each phase of the cell cycle.

Hours after release G0/G1 (%) S (%) G2+M (%) Sub-G1 (%)
0hr
pBABE-Hygro 64.23 ± 10.43 4.7 ± 3.92 30.57 ± 13.73 0.5 ± 0.32
E2F1/E2F2/E2F3a 79.030 ± 5.77 3.83±0.56 14 ± 5.59 3.13 ± 0.81*
12hr
pBABE-Hygro 71.23 ± 0.5 5.23 ± 2.53 21.53 ± 2.63 2 ± 0.81
E2F1/E2F2/E2F3a 79.8 ± 0.78* 4.83 ± 1.73 14.73 ± 2.01* 0.67 ± 0.13
18hr
pBABE-Hygro 43.37 ± 17.09 35.57 ± 20.67 19.33 ± 2.91 1.73 ± 0.8
E2F1/E2F2/E2F3a 40.13 ± 7.53 48.43 ± 10.63 10.87 ± 3.43 0.57 ± 0.23
24hr
pBABE-Hygro 34.9 ± 11.57 34.4 ±10.8 15.87 ± 0.75 14.8 ± 13.92
E2F1/E2F2/E2F3a 54.97 ± 6.89 24.3 ±12.08 19.8 ± 4.94 0.97 ± 0.39

*p≤0.05